AbbreviationsCIconfidence intervalCScesarean sectionGAgestational agePSpropensity scoreRCTrandomized controlled trialRRrelative riskKey messageLabor induction decreases the risk for meconium aspiration syndrome (between 40+0 and 41+4) but increases the risk for cesarean section around 41 weeks. Close to 42 weeks, labor induction does not confer any additional risk or benefit compared with expectant management.IntroductionRisks related to prolonged pregnancy are well recognized. Post‐term (42+0 weeks or more) and even late‐term births (41+0–41+6 weeks) are known to be associated with increased risks compared with term period (39+0–40+6 weeks), from both a maternal and a neonatal perspective . Proactive management is suggested to decrease the risks, and existing evidence mostly favors labor induction over expectant management . It is crucial, however, to acknowledge that nearly every fourth pregnancy continues beyond term, and choosing to induce most of them has a substantial impact on the obstetric care as a whole .There are an exhaustive number of studies on the impact of labor induction on maternal and neonatal outcomes. Induction seems to improve neonatal outcomes but the impact on the risk for emergency cesarean section (CS) is not clearly established . Observational setups are justifiably criticized for their methodological issues; unrecognized or uncontrollable confounders, and even wrong control groups (comparing labor induction with spontaneous
Acta Obstetricia Et Gynecologica Scandinavica – Wiley
Published: Jan 1, 2018
Keywords: ; ; ; ; ; ; ;
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.
Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.
It’s easy to organize your research with our built-in tools.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera